EGFR-Based Targeted Therapy for Colorectal Cancer—Promises and Challenges

EGFR-Based Targeted Therapy for Colorectal Cancer—Promises and Challenges

Colorectal carcinoma (CRC) is the most lethal and common form of cancer in the world. It was responsible for almost 881,000 cancer deaths in 2018. Approximately 25% of cases are diagnosed at advanced stages with metastasis—this poses challenges for effective surgical control and future tumor-related...

Full description

Bibliographic Details
Main Authors: Balakarthikeyan Janani, Mayakrishnan Vijayakumar, Kannappan Priya, Jin Hee Kim, D. S. Prabakaran, Mohammad Shahid, Sameer Al-Ghamdi, Mohammed Alsaidan, Nasraddin Othman Bahakim, Mohammad Hassan Abdelzaher, Thiyagarajan Ramesh
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Vaccines
Subjects:
colorectal cancer
EGFR
nanocarriers
nanomedicine
cetuximab
Online Access:https://www.mdpi.com/2076-393X/10/4/499

Internet

https://www.mdpi.com/2076-393X/10/4/499

Similar Items